Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J.M. Galvin

Knowledge Engineering-Based Quality Evaluation of NRG Oncology RTOG 0522 Treatment Plans

International Journal of Radiation Oncology Biology Physics

English

Related publications

Knowledge Engineering–Based Quality Evaluation of RTOG 1308 Photon Treatment Plans

International Journal of Radiation Oncology Biology Physics

English

Comparisons of Outcome Prediction Performance Between Radiomics Features and Clinical Features Based on NRG Oncology/ RTOG-0522

International Journal of Radiation Oncology Biology Physics

English

Toward Improving Treatment Planning Quality and Efficiency Using Knowledge Engineering and Autoplanning: A Study Based on NRG-HN001 Clinical Trial

International Journal of Radiation Oncology Biology Physics

English

NRG Oncology/Rtog 0415, Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer: Prostate-Specific Quality of Life Results

International Journal of Radiation Oncology Biology Physics

English

A Phase II Evaluation of Nintedanib (BIBF-1120) in the Treatment of Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study

English

OA01.01 10-Year Updated Analysis of NRG Oncology/Rtog 0214: A Phase III Comparison of PCI vs. Observation in Patients With LA-NSCLC.

Journal of Thoracic Oncology

English

A Mutation and Prognostic Biomarker Study in Grade II and III Gliomas Utilizing a Combined Cohort of NRG Oncology/Rtog 9802 and 9813

International Journal of Radiation Oncology Biology Physics

English

Pretreatment Volume of MRI-determined White Matter Injury (WMI) Predicts Neurocognitive Decline After Hippocampal Avoidant (HA) WBRT for Brain Metastases: Secondary Analysis of NRG Oncology RTOG 0933

Advances in Radiation Oncology

English

A Phase II Evaluation of Selumetinib (AZD6244, ARRY-142886), a Selective MEK-1/2 Inhibitor in the Treatment of Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J.M. Galvin

Knowledge Engineering-Based Quality Evaluation of NRG Oncology RTOG 0522 Treatment Plans

Related publications

Knowledge Engineering–Based Quality Evaluation of RTOG 1308 Photon Treatment Plans

Comparisons of Outcome Prediction Performance Between Radiomics Features and Clinical Features Based on NRG Oncology/ RTOG-0522

Toward Improving Treatment Planning Quality and Efficiency Using Knowledge Engineering and Autoplanning: A Study Based on NRG-HN001 Clinical Trial

NRG Oncology/Rtog 0415, Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer: Prostate-Specific Quality of Life Results

A Phase II Evaluation of Nintedanib (BIBF-1120) in the Treatment of Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study

OA01.01 10-Year Updated Analysis of NRG Oncology/Rtog 0214: A Phase III Comparison of PCI vs. Observation in Patients With LA-NSCLC.

A Mutation and Prognostic Biomarker Study in Grade II and III Gliomas Utilizing a Combined Cohort of NRG Oncology/Rtog 9802 and 9813

Pretreatment Volume of MRI-determined White Matter Injury (WMI) Predicts Neurocognitive Decline After Hippocampal Avoidant (HA) WBRT for Brain Metastases: Secondary Analysis of NRG Oncology RTOG 0933

A Phase II Evaluation of Selumetinib (AZD6244, ARRY-142886), a Selective MEK-1/2 Inhibitor in the Treatment of Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study